ArticleBlood cancer journal2021

Economic burden of disease progression among multiple myeloma patients who have received transplant and at least one line of therapy in the US.

Rafael Fonseca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.